ADA: Once-Weekly Dulaglutide Ups Glycemic Control in Youth W

TUESDAY, June 7, 2022 (HealthDay News) -- For youth with type 2 diabetes, dulaglutide is superior to placebo for reducing mean glycated hemoglobin level, according to a study published online

Related Keywords

United States , American , Silvaa Arslanian , Eli Lilly , University Of Pittsburgh School Medicine , American Diabetes Association , Healthday News , New England Journal , Pittsburgh School , Physicians Briefing ,